Upside | ||||||
|---|---|---|---|---|---|---|
| ABT | 5.40% | aa.aa | 134.80 | +1.09% | 95,301 | |
| JNJ | 4.96% | aa.aa | 151.33 | +1.15% | 77,932 | |
| GILD | 4.95% | aa.aa | 102.50 | +2.15% | 116,057 | |
| ABBV | 4.90% | aa.aa | 184.02 | +1.29% | 63,406 | |
| AMGN | 4.74% | aa.aa | 272.41 | +0.27% | 41,009 | |
| PFE | 4.65% | aa.aa | 22.83 | +1.02% | 484,060 | |
| MRK | 4.50% | aa.aa | 76.06 | +1.68% | 141,570 | |
| LLY | 4.47% | aa.aa | 757.39 | +3.29% | 14,353 | |
| LQDA | 3.74% | aa.aa | 18.880 | -2.18% | 456,021 | |
| CORT | 3.60% | aa.aa | 75.08 | +2.34% | 115,307 |
Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of large-cap companies. It seeks to track the performance of the Dynamic Pharmaceutical Intellidex Index, by using full replication technique. Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF was formed on June 23, 2005 and is domiciled in the United States.